Nexgel (NXGLW) Return on Sales (2018 - 2025)

Nexgel (NXGLW) has 8 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales declined to 0.0% in Q4 2025, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2025 to a low of 0.05% in Q1 2022.
• A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2021 — Return on Sales grew 5 bps — and 2022, when it fell 2 bps.
• Tracing NXGLW's Return on Sales over 5 years: stood at 0.03% in 2021, then soared by 63 bps to 0.01% in 2022, then advanced by 11 bps to 0.01% in 2023, then soared by 75 bps to 0.0% in 2024, then decreased by 22 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.